# FDA recall D-1133-2017

> **ImprimisRx CA, Inc., dba ImprimisRx** · Class II · drug recall initiated 2017-06-23.

## Product

Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA

## Reason for recall

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1133-2017
- **Recalling firm:** ImprimisRx CA, Inc., dba ImprimisRx
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-06-23
- **Report date:** 2017-09-13
- **Termination date:** 2019-01-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Irvine, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1133-2017

## Citation

> AI Analytics. FDA recall D-1133-2017. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-1133-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*